Celgene Corporation announced that data from more than 60 company-sponsored, cooperative group and investigator-initiated clinical studies evaluating Celgene agents will...
Eli Lilly and Company announced that galcanezumab met its primary endpoint in a Phase 3 study of patients with episodic...
AbbVie , a research-based global biopharmaceutical company, announced it will present data about the company's portfolio of investigational oncology medicines...
Teva Pharmaceutical Industries Ltd. announced the publication of data from the Phase III HALO study evaluating the efficacy, safety, and...
CPhI & P-MEC China – organized by UBM and UBM SINEXPO – takes place at the Shanghai New International Expo...
Novartis will present data from across its oncology portfolio at the upcoming 54th Annual Meeting of the American Society of...
Astellas is pleased to announce that Bernhardt G. Zeiher, M.D., F.C.C.P., F.A.C.P., ("Bernie"), was promoted to Chief Medical Officer (CMO),...
HDA’s Pharmaceutical Cargo Security Coalition (PCSC) presented three awards at its educational seminar in East Hanover, New Jersey. Presented annually,...
PAREXEL International Corporation, the world’s leading innovator of biopharmaceutical services, announced that Josef von Rickenbach, PAREXEL co-founder and Chairman of...
Novartis announced the plan to initiate ARROW, a head-to-head proof of concept study to assess the mechanistic superiority of the...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
